Ingevity Corporation (NGVT)
| Market Cap | 2.40B +52.7% |
| Revenue (ttm) | 1.18B +6.3% |
| Net Income | -127.80M |
| EPS | -3.56 |
| Shares Out | 34.77M |
| PE Ratio | n/a |
| Forward PE | 13.69 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1 |
| Open | 68.95 |
| Previous Close | 68.93 |
| Day's Range | 68.93 - 68.95 |
| 52-Week Range | n/a |
| Beta | 1.24 |
| Analysts | Buy |
| Price Target | n/a |
| Earnings Date | May 6, 2026 |
About NGVT
Ingevity Corporation manufactures and sells activated carbon products, derivative specialty chemicals, and engineered polymers in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. It operates through three segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies. The Performance Materials segment engineers, manufactures, and sells hardwood-based and chemically activated carbon products for use in gasoline vapor emission control systems in cars, trucks, motorcycles, and boats. T... [Read more]
Financial Performance
In 2025, Ingevity's revenue was $1.17 billion, a decrease of -2.71% compared to the previous year's $1.20 billion. Losses were -$167.10 million, -61.17% less than in 2024.
Financial StatementsNews
Ingevity Q1 Earnings Call Highlights
Ingevity NYSE: NGVT reported higher first-quarter 2026 sales and reaffirmed its full-year outlook as management highlighted progress on portfolio simplification, strong margins in its Performance Mate...
Ingevity Earnings Call Transcript: Q1 2026
Q1 2026 saw 4% sales growth, strong EBITDA margins, and accelerated share repurchases, driven by portfolio simplification and robust Performance Materials results. Guidance for 2026 is reaffirmed, with continued focus on debt reduction and share buybacks.
Ingevity Earnings release: Q1 2026
Ingevity released its Q1 2026 earnings on May 7, 2026, summarizing the period's financial results.
Ingevity Slides: Q1 2026
Ingevity has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on May 7, 2026.
Ingevity Quarterly report: Q1 2026
Ingevity has published its Q1 2026 quarterly earnings report on May 7, 2026.
Ingevity reports Q1 adjusted EPS $1.15, consensus 83c
Reports Q1 revenue $258.0M, consensus $254.73M. The company said, “Closing both the Industrial Specialties and Road Markings divestitures early in the year was a significant achievement and enabled us...
Ingevity afforms 2026 adjusted EPS outlook $4.70-$5.20, consensus $4.80
Affirms 2025 revenue outlook $1.05B-$1.15B, consensus $1.19B.
Ingevity reports first quarter 2026 financial results
NORTH CHARLESTON, S.C.--(BUSINESS WIRE)-- #ingevity--Ingevity reports first quarter 2026 financial results.
Ingevity Transcript: AGM 2026
The meeting saw the election of nine directors and approval of all shareholder proposals. 2025 financials showed strong free cash flow and improved debt metrics, with plans to generate $1 billion in deployable cash over two years. No questions were raised by stockholders.
PPG acquires pavement markings manufacturer Ozark Materials, LLC
PITTSBURGH--(BUSINESS WIRE)--PPG (NYSE:PPG) today announced that it has completed the acquisition of Ozark Materials, LLC, a U.S.-based provider of pavement marking solutions, from Ingevity Corporatio...
Ingevity announces sale of Ozark Materials road markings business to PPG, strengthening strategic focus
NORTH CHARLESTON, S.C.--(BUSINESS WIRE)-- #ingevity--Ingevity has signed a definitive agreement and has successfully closed on the sale of its Ozark Materials road markings business to PPG.
Ingevity announces dates for first quarter 2026 earnings release and webcast
NORTH CHARLESTON, S.C.--(BUSINESS WIRE)-- #ingevity--Ingevity announced today that it will release its first quarter 2026 earnings after the stock market close on Wednesday, May 6, 2026.
Ingevity Transcript: Gabelli Funds Annual Specialty Chemicals Symposium
The company is undergoing a major transformation, divesting non-core assets and focusing on two highly profitable segments: Performance Materials and Pavement Technologies. With $1 billion in deployable cash expected over two years, priorities include organic growth, debt reduction, and share repurchases.
Ingevity Proxy statement: Proxy Filing
Ingevity filed a proxy statement on March 17, 2026, providing details for shareholder voting and corporate governance matters.
Ingevity Proxy statement: Proxy Filing
Ingevity filed a proxy statement on March 17, 2026, providing details for shareholder voting and corporate governance matters.
Ingevity Earnings Call Transcript: Q4 2025
Adjusted EBITDA grew 10% to $398M with margins above 30%, despite an 8% sales decline and $167M GAAP net loss due to special charges. Free cash flow hit $274M, leverage dropped to 2.6x, and 2026 guidance projects stable margins and continued share buybacks.
Ingevity Annual report: Q4 2025
Ingevity has published its Q4 2025 annual report on February 26, 2026.
Ingevity Earnings release: Q4 2025
Ingevity released its Q4 2025 earnings on February 26, 2026, summarizing the period's financial results.
Ingevity Slides: Q4 2025
Ingevity has posted slides in relation to its Q4 2025 quarterly earnings report, which was published on February 26, 2026.
Ingevity reports Q4 adjusted EPS 64c, consensus 65c
Reports Q4 revenue $278M, consensus $237.8M. “Despite a volatile macro environment, which included tariff uncertainty and supply chain disruptions, Ingevity (NGVT) delivered very strong business and f...
Ingevity sees FY26 adjusted EPS $4.80-$5.20, consensus $4.47
Sees FY26 revenue $1.1B-$1.2B, consensus $1.13B.
Ingevity reports full year and fourth quarter 2025 financial results
NORTH CHARLESTON, S.C.--(BUSINESS WIRE)-- #ingevity--Ingevity (NYSE:NGVT) today reported the company's full year and fourth quarter 2025 financial results.
Ingevity announces upcoming board transitions
NORTH CHARLESTON, S.C.--(BUSINESS WIRE)-- #ingevity--Founding directors Daniel F. Sansone and Jean S. Blackwell to conclude board service at the Ingevity 2026 Annual Meeting.
Ingevity announces dates for fourth quarter and full year 2025 earnings release and webcast
NORTH CHARLESTON, S.C.--(BUSINESS WIRE)-- #ingevity--Ingevity announced that it will release its fourth quarter and full year 2025 earnings after the stock market close on Wednesday, February 25, 2026...
Ingevity price target raised to $65 from $60 at Wells Fargo
Wells Fargo raised the firm’s price target on Ingevity (NGVT) to $65 from $60 and keeps an Equal Weight rating on the shares. The firm is adjusting its estimates for…